{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:09:47Z","timestamp":1790716187710,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.bcmd.2010.08.002","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T04:31:42Z","timestamp":1283833902000},"page":"317-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Sonali M.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Anastasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy A.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2010.08.002_bb0005","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2141.2010.08159.x","article-title":"Advances in the understanding of MYC-induced lymphomagenesis","volume":"149","author":"Klapproth","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-230X(10)07006-5","article-title":"MYC in oncogenesis and as a target for cancer therapies","volume":"107","author":"Albihn","year":"2010","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.semcancer.2006.07.014","article-title":"The c-Myc target gene network","volume":"16","author":"Dang","year":"2006","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0020","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.cellbio.16.1.653","article-title":"The Myc\/Max\/Mad network and the transcriptional control of cell behavior","volume":"16","author":"Grandori","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0025","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1038\/sj.onc.1206800","article-title":"c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis","volume":"22","author":"Kanazawa","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0030","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S1097-2765(03)00173-4","article-title":"Skp2 regulates Myc protein stability and activity","volume":"11","author":"Kim","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0035","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.4161\/cc.6.16.4554","article-title":"P-TEFb is a crucial co-factor for Myc transactivation","volume":"6","author":"Gargano","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.1987636","article-title":"Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region","volume":"251","author":"Prendergast","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(91)90457-A","article-title":"Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation","volume":"65","author":"Prendergast","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.emboj.7600509","article-title":"Myc represses transcription through recruitment of DNA methyltransferase corepressor","volume":"24","author":"Brenner","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0055","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrm1703","article-title":"Transcriptional regulation and transformation by Myc proteins","volume":"6","author":"Adhikary","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0060","first-page":"145","article-title":"Myc target transcriptomes","volume":"302","author":"Lee","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0065","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1101\/gad.1712408","article-title":"Myc's broad reach","volume":"22","author":"Eilers","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0070","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc2819","article-title":"MYC as a regulator of ribosome biogenesis and protein synthesis","volume":"10","author":"van Riggelen","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0075","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0092-8674(04)00127-8","article-title":"Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs","volume":"116","author":"Cawley","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/ng1532","article-title":"Reverse engineering of regulatory networks in human B cells","volume":"37","author":"Basso","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0085","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0b013e3181db83af","article-title":"Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation","author":"Ruzinova","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0092-8674(00)81479-8","article-title":"The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins","volume":"94","author":"McMahon","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1139\/O08-113","article-title":"The role of INI1\/hSNF5 in gene regulation and cancer","volume":"87","author":"Stojanova","year":"2009","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0100","doi-asserted-by":"crossref","first-page":"46562","DOI":"10.1074\/jbc.M104937200","article-title":"A novel transrepression pathway of c-Myc. Recruitment of a transcriptional corepressor complex to c-Myc by MM-1, a c-Myc-binding protein","volume":"276","author":"Satou","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1097-2765(01)00430-0","article-title":"Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B)","volume":"9","author":"Feng","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0110","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1242\/jcs.114.8.1533","article-title":"Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor","volume":"114","author":"Izumi","year":"2001","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0115","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ccr.2007.07.006","article-title":"HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation","volume":"12","author":"Gordan","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.19.1.1","article-title":"c-Myc target genes involved in cell growth, apoptosis, and metabolism","volume":"19","author":"Dang","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0125","doi-asserted-by":"crossref","first-page":"e2722","DOI":"10.1371\/journal.pone.0002722","article-title":"Global regulation of nucleotide biosynthetic genes by c-Myc","volume":"3","author":"Liu","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0130","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1128\/MCB.25.14.6225-6234.2005","article-title":"Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis","volume":"25","author":"Li","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0135","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","article-title":"MYC-induced cancer cell energy metabolism and therapeutic opportunities","volume":"15","author":"Dang","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0140","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2009.10.009","article-title":"HIF-1: upstream and downstream of cancer metabolism","volume":"20","author":"Semenza","year":"2010","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0150","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3858\/emm.2009.41.12.103","article-title":"Hypoxia and angiogenesis: regulation of hypoxia-inducible factors via novel binding factors","volume":"41","author":"Chen","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0155","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.4161\/cc.8.9.8215","article-title":"Growth controls connect: interactions between c-myc and the tuberous sclerosis complex\u2013mTOR pathway","volume":"8","author":"Schmidt","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0160","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/0008-5472.CAN-09-3556","article-title":"Rethinking the Warburg effect with Myc micromanaging glutamine metabolism","volume":"70","author":"Dang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0165","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1073\/pnas.0901230107","article-title":"Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell model","volume":"107","author":"Yustein","year":"2010","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0170","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/MCB.00440-07","article-title":"Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1","volume":"27","author":"Kim","year":"2007","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0175","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1038\/sj.onc.1203589","article-title":"Angiogenesis is an early event in the generation of myc-induced lymphomas","volume":"19","author":"Brandvold","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0180","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/S0002-9440(10)63581-X","article-title":"B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis","volume":"163","author":"Ruddell","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/10428190310001607151","article-title":"The interplay between c-Myc oncogene expression and circulating vascular endothelial growth factor (sVEGF), its antagonist receptor, soluble Flt-1 in diffuse large B cell lymphoma (DLBCL): relationship to patient outcome","volume":"45","author":"Aref","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0190","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1158\/0008-5472.CAN-08-4603","article-title":"Targeting angiogenesis via a c-Myc\/hypoxia-inducible factor-1 alpha-dependent pathway in multiple myeloma","volume":"69","author":"Zhang","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0195","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0200","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"T.I.N.-H.s.L.P.F. Project","year":"1993","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0205","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","article-title":"The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP","volume":"109","author":"Sehn","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0210","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","article-title":"Standard International Prognostic Index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era","volume":"28","author":"Ziepert","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0215","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0220","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/asheducation-2007.1.265","article-title":"Molecular signatures define new rational treatment targets in large B-cell lymphomas","author":"Shipp","year":"2007","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0225","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0230","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0235","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.26.3947","article-title":"Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab","author":"Barrans","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0240","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/leu.2008.230","article-title":"Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)","volume":"22","author":"Klapper","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0245","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1349-7006.2008.01035.x","article-title":"Clinical significance of 8q24\/c-MYC translocation in diffuse large B-cell lymphoma","volume":"100","author":"Niitsu","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0250","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0255","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1200\/JCO.2009.22.7058","article-title":"Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study","volume":"27","author":"Copie-Bergman","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0260","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/leu.2008.312","article-title":"Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB\/LMB 96 international study","volume":"23","author":"Poirel","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0265","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in folllicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0270","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/PAS.0b013e3181cd3aeb","article-title":"B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma","volume":"34","author":"Snuderl","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0275","first-page":"147","article-title":"Clinical, morphologic, and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8;14)(q24;q32) or t(8;22)(q24;q11)","volume":"2","author":"Thangavelu","year":"1990","journal-title":"Genes Chr. Cancer"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0280","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":"Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis","volume":"19","author":"Kanungo","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0290","first-page":"777","article-title":"The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC translocations","volume":"23","author":"Le Gouill","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0295","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/leu.2008.344","article-title":"Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC translocations","volume":"23","author":"Niitsu","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0300","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.humpath.2008.06.032","article-title":"BCL2, BCL6, MYC, MALT1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome","volume":"40","author":"Tibilatti","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0305","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/10428190801947542","article-title":"Double trouble in follicular lymphoma: a rare and unusual synergy of oncogenes in the germinal center","volume":"49","author":"Alizadeh","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0310","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/10428190701836845","article-title":"C-MYC translocation in t(14;18) positive follicular lymphoma at presentation: an adverse prognostic indicator?","volume":"49","author":"Christie","year":"2008","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0315","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2006.06439.x","article-title":"Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms","volume":"136","author":"Davies","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0320","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/01.MP.0000037310.82136.99","article-title":"mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features","volume":"15","author":"Hao","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0325","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2141.2009.07791.x","article-title":"Detection of gene copy number aberrations in mantle cell lymphoma by a single multiplex PCR assay: clinicopathological relevance and prognosis value","volume":"146","author":"Jardin","year":"2009","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0330","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1200\/JCO.2007.12.0410","article-title":"Five-gene model to predict survival in mantle-cell lymphoma using frozen or formalin-fixed, paraffin-embedded tissue","volume":"26","author":"Hartmann","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0335","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1158\/0008-5472.CAN-07-6398","article-title":"Novel and highly recurrent chromosomal alterations in Sezary syndrome","volume":"15","author":"Vermeer","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcmd.2010.08.002_bb0340","first-page":"37","article-title":"Chromosomal aberrations in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma unspecified: a matrix-based CGH approach","volume":"46","author":"Thorns","year":"2007","journal-title":"Genes Chr. Cancer"},{"key":"10.1016\/j.bcmd.2010.08.002_bb0345","first-page":"613","article-title":"Pediatric leukemia\/lymphoma with t(8;14)(q24;q11)","volume":"6","author":"Lange","year":"1992","journal-title":"Leukemia"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979610002007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:27:45Z","timestamp":1761049665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979610002007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S1079979610002007"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.08.002","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2010.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}